The significance of delayed suppression using buserelin acetate and recombinant follicle-stimulating hormone in a long protocol in vitro fertilization program

MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE

Judith Adams, D. W. POLSON, N. A. Abdulwahid et al. · The Lancet · 1985 · 809 citations

Medicine, Endocrinology, Physiology +12

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

Henk J. Out, Bernadette Mannaerts, Stefan Driessen et al. · Human Reproduction · 1995 · 214 citations

Medicine, Endocrinology, Gynecology +17

Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization

S Neveu, B. Hédon, J. Bringer et al. · Fertility and Sterility · 1987 · 198 citations

Medicine, Endocrinology, Gynecology +13

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone

R. Fleming, F. Lloyd, Mary Herbert et al. · Human Reproduction · 1998 · 163 citations · Full text

Medicine, Endocrinology, Gynecology +17

Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone

Alison Rutherford, Robert Subak-Sharpe, Karin J. Dawson et al. · BMJ · 1988 · 155 citations · Full text

Medicine, Endocrinology, Gynecology +12